| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6124 |
| Human Intestinal Absorption | HIA+ | 0.8410 |
| Caco-2 Permeability | Caco2+ | 0.6328 |
| P-glycoprotein Substrate | Substrate | 0.6909 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9914 |
| Non-inhibitor | 0.9525 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8902 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6993 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7156 |
| CYP450 2D6 Substrate | Non-substrate | 0.8090 |
| CYP450 3A4 Substrate | Non-substrate | 0.5272 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6923 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8299 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9089 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7884 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.6451 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9477 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8809 |
| Non-inhibitor | 0.8366 |
| AMES Toxicity | Non AMES toxic | 0.9152 |
| Carcinogens | Non-carcinogens | 0.9508 |
| Fish Toxicity | High FHMT | 0.9352 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9382 |
| Honey Bee Toxicity | High HBT | 0.6302 |
| Biodegradation | Ready biodegradable | 0.5675 |
| Acute Oral Toxicity | III | 0.4663 |
| Carcinogenicity (Three-class) | Non-required | 0.7332 |